Loading…
Loading…
Structured register of government actions in the geoeconomic space — export controls, tariffs, sanctions, FDI screening, subsidies, industrial-policy laws — cross-referenced into the country, minerals, and ETF surface. Charter: docs/IPTM_CHARTER.md.
Severity 1-5 is the qualitative impact rating (1=minor, 5=structural). The bilateral-trade-grounded quant scorer is the next IPTM milestone. RBI (Register Breadth Index) is a complementary structural-breadth indicator from scripts/py/iptm/breadth.py; divergence between RBI and severity is itself informative (high-sev / low-RBI = strategic chokepoint; low-sev / high-RBI = broad but shallow). Every action has at least one primary source URL. Verify-or-don't-file. See also themes, timeline, graph, sankey, map, country exposure, sector exposure, material exposure (+ graph), weekly briefs, portfolio scan, escalation monitor, trans-shipment hubs. Internal triage tools (RSS-poller candidate feed, source-feed health) live under /admin/candidates + /admin/sources. Subscribe via Atom feed (accepts ?country=CN, ?material=lithium, ?issuer=BIS, ?type=export_control, ?etf=SOXX, ?company=NVDA, ?minSeverity=4, ?year=2026, ?q=…) or pull /api/iptm/actions.
The Clean Energy Finance Corporation (CEFC), Australia's government-owned green bank, approved a senior project finance loan of up to USD 47 million to Salt Lake Potash Ltd (ASX/AIM: SO4), part of a USD 138 million syndicated senior debt facility (alongside Taurus Mining Finance Fund No. 2) to build the Lake Way sulphate-of-potash (SOP) brine project near Wiluna, Western Australia. The facility funds construction of Australia's first greenfield SOP brine operation, part-powered by a 5MW solar farm and 2MW battery, targeted at cutting SOP production emissions by more than 30% versus conventional non-brine methods.
The Department of Pharmaceuticals notified the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs), Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) on 21 July 2020 via Gazette Notification, with an outlay of Rs 6,940 crore (~USD 920m) over FY 2020-21 to FY 2027-28. The scheme covers 41 identified critical bulk-drug products across four target segments — fermentation-based (Key Fermentation; Niche Fermentation) and chemical synthesis-based (Key Chemical Synthesis; Niche Chemical Synthesis) — paying 20% incentive on incremental sales for fermentation-based products (years 1-4) tapering to 15% (year 5) and 5% (year 6), and a flat 20% over 5 years for chemically-synthesised products. The stated objective is to reduce India's ~70% bulk-drug import dependence on China by establishing greenfield domestic manufacturing capacity with at least 90% domestic value addition for fermentation products and 70% for chemical-synthesis products.
The Nordic Investment Bank (NIB), a multilateral development bank owned by the eight Nordic and Baltic member states, signed an 8-year EUR 100 million loan with Swedish mining and smelting group Boliden Mineral AB. The loan finances an expansion of the Kevitsa copper-nickel-PGM mine in Finnish Lapland (raising ore throughput from 7.8 to 9.5 million tonnes/year) and a new leaching plant at the Rönnskär copper smelter in northern Sweden that converts smelter residues into saleable lead and copper/zinc sulphate.